drugset / Trial / NCT00994123
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
A Phase 1-2 study of MM-121 in combination with standard therapy for non-small cell lung cancer (NSCLC).
Timeline
- Start
- 2010-02
- Primary completion
- 2014-11
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erlotinib | Small molecule | — | Oral |
| Subject | Seribantumab | Monoclonal antibody | — | Intravenous |